Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Plos One
|
March 26, 2019
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas
Guillaume Beinse, Pierre-Alexandre Just, Bastien Rance, et al.
Oncotarget
|
March 7, 2018
Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non-tumorigenic cells
Nathaniel Edward Bennett Saidu, Marie Bretagne, Audrey Lupo Mansuet, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 12, 2025
Improved tumor-type informed compared to tumor-informed mutation tracking for ctDNA detection and microscopic residual disease assessment in epithelial ovarian cancer
Mehdi Ben Sassi, Henri Azais, Charles Marcaillou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 15, 2020
Identification of <i>TP53</i> mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments
Guillaume Beinse, Bastien Rance, Pierre-Alexandre Just, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 20, 2017
Clinicopathologic Characteristics of Endometrial Cancer in Lynch Syndrome: A French Multicenter Study
Léa Rossi, Marie-Aude Le Frere-Belda, Pierre Laurent-Puig, et al.
Gynecologic Oncology
|
June 1, 2022
Potential competing risk of death in older high-risk endometrial carcinoma patients: Results from a multicentric retrospective cohort
Violaine Gorgeu, Bruno Borghese, Meriem Koual, et al.
Clinical Chemistry
|
March 24, 2022
Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma
Guillaume Beinse, Bruno Borghese, Marie Métairie, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 14, 2025
Identification of a very-high risk subgroup of localized endometrial carcinoma before surgery using circulating tumor DNA: a proof-of-concept study
Antoine Gaudet Chardonnet, Bruno Borghese, Jérôme Alexandre, et al.
British Journal of Cancer
|
June 25, 2022
Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers
Guillaume Beinse, Pierre-Alexandre Just, Marie-Aude Le Frere Belda, et al.
Gynecologic Oncology
|
January 16, 2022
Development and validation of a RNAseq signature for prognostic stratification in endometrial cancer
Guillaume Beinse, Marie-Aude Le Frere Belda, Pierre-Alexandre Just, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Plos One
|
March 26, 2019
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas
Guillaume Beinse, Pierre-Alexandre Just, Bastien Rance, et al.
Oncotarget
|
March 7, 2018
Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non-tumorigenic cells
Nathaniel Edward Bennett Saidu, Marie Bretagne, Audrey Lupo Mansuet, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 12, 2025
Improved tumor-type informed compared to tumor-informed mutation tracking for ctDNA detection and microscopic residual disease assessment in epithelial ovarian cancer
Mehdi Ben Sassi, Henri Azais, Charles Marcaillou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 15, 2020
Identification of <i>TP53</i> mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments
Guillaume Beinse, Bastien Rance, Pierre-Alexandre Just, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 20, 2017
Clinicopathologic Characteristics of Endometrial Cancer in Lynch Syndrome: A French Multicenter Study
Léa Rossi, Marie-Aude Le Frere-Belda, Pierre Laurent-Puig, et al.
Gynecologic Oncology
|
June 1, 2022
Potential competing risk of death in older high-risk endometrial carcinoma patients: Results from a multicentric retrospective cohort
Violaine Gorgeu, Bruno Borghese, Meriem Koual, et al.
Clinical Chemistry
|
March 24, 2022
Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma
Guillaume Beinse, Bruno Borghese, Marie Métairie, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 14, 2025
Identification of a very-high risk subgroup of localized endometrial carcinoma before surgery using circulating tumor DNA: a proof-of-concept study
Antoine Gaudet Chardonnet, Bruno Borghese, Jérôme Alexandre, et al.
British Journal of Cancer
|
June 25, 2022
Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers
Guillaume Beinse, Pierre-Alexandre Just, Marie-Aude Le Frere Belda, et al.
Gynecologic Oncology
|
January 16, 2022
Development and validation of a RNAseq signature for prognostic stratification in endometrial cancer
Guillaume Beinse, Marie-Aude Le Frere Belda, Pierre-Alexandre Just, et al.
Page
of 10